Entero Therapeutics, Inc. (ENTO)
NASDAQ: ENTO · Real-Time Price · USD
0.493
-0.032 (-6.04%)
Feb 21, 2025, 4:00 PM EST - Market closed
Entero Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -9.92 | -15.79 | -14.63 | -58.54 | -32.67 | -15.18 | Upgrade
|
| Depreciation & Amortization | 0.06 | 0.03 | 0.03 | 0.54 | 0.57 | 0.64 | Upgrade
|
| Other Amortization | 0.01 | - | - | - | 4.58 | 0.7 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 2.35 | 0.01 | 0.01 | Upgrade
|
| Stock-Based Compensation | 6.28 | 1.13 | 0.97 | 6.79 | 0.72 | 1.39 | Upgrade
|
| Other Operating Activities | -10.53 | 0.06 | 1.79 | -0.54 | 1.43 | 0.11 | Upgrade
|
| Change in Accounts Receivable | - | 0.09 | -0.09 | 0.55 | 2.08 | -0.75 | Upgrade
|
| Change in Accounts Payable | 0.88 | -0.17 | -1.99 | 1.42 | -0.75 | -0.42 | Upgrade
|
| Change in Other Net Operating Assets | 0.75 | 2.26 | -8.42 | 15.13 | 12.82 | -0.53 | Upgrade
|
| Operating Cash Flow | -12.49 | -12.38 | -22.34 | -32.29 | -11.22 | -14.03 | Upgrade
|
| Capital Expenditures | - | - | - | -0.07 | -0 | -0.02 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | 0.09 | - | Upgrade
|
| Cash Acquisitions | 0.09 | - | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.5 | -0.5 | - | -10.25 | - | - | Upgrade
|
| Investing Cash Flow | -0.41 | -0.5 | - | -10.32 | 0.09 | -0.02 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 0.09 | 4.03 | 5.47 | Upgrade
|
| Total Debt Issued | 0.03 | - | - | 0.09 | 4.03 | 5.47 | Upgrade
|
| Short-Term Debt Repaid | - | -0.6 | -0.64 | - | -1.17 | -1.86 | Upgrade
|
| Total Debt Repaid | -0.64 | -0.6 | -0.64 | - | -1.17 | -1.86 | Upgrade
|
| Net Debt Issued (Repaid) | -0.61 | -0.6 | -0.64 | 0.09 | 2.86 | 3.61 | Upgrade
|
| Issuance of Common Stock | 10.58 | 15.83 | 23.1 | 37.57 | 0.99 | 9.48 | Upgrade
|
| Other Financing Activities | - | - | -6.91 | - | - | 0.06 | Upgrade
|
| Financing Cash Flow | 9.97 | 15.23 | 15.74 | 44.76 | 17.05 | 13.14 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | -0.26 | 0.03 | -0.03 | -0.03 | Upgrade
|
| Net Cash Flow | -2.93 | 2.35 | -6.86 | 2.19 | 5.89 | -0.94 | Upgrade
|
| Free Cash Flow | -12.49 | -12.38 | -22.34 | -32.36 | -11.23 | -14.06 | Upgrade
|
| Free Cash Flow Per Share | -5.10 | -36.80 | -622.19 | - | - | - | Upgrade
|
| Cash Interest Paid | 0.04 | 0.02 | 0.02 | 0.01 | 0.11 | 0.01 | Upgrade
|
| Levered Free Cash Flow | -75.33 | -7.76 | -17.58 | -45.18 | -0.63 | -6.39 | Upgrade
|
| Unlevered Free Cash Flow | -75.33 | -7.75 | -17.57 | -45.18 | -1.56 | -6.43 | Upgrade
|
| Change in Net Working Capital | 69.6 | -1.44 | 10.64 | 2.72 | -13.68 | -0.39 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.